Table 5 Univariate and multivariate analyses for lung cancer patients on disease‐free survival in the GSE30219
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age (≤ 55 vs > 55 years) | 1.027 (1.009–1.045) | 0.003 | 1.029 (1.010–1.048) | 0.003 |
Gender | ||||
Female vs male | 0.746 (0.433-1.285) | 0.290 | ||
T stage | ||||
T1 vs T2 vs T3 vs T4 | 1.882 (1.587–2.232) | 0.000 | 1.309 (1.027–1.670) | 0.030 |
N stage | ||||
N0 vs N1 vs N2 vs N4 | 2.618 (1.791–2.624) | 0.000 | 1.652 (1.259–2.169) | 0.000 |
M stage | ||||
M0 vs M1 | 3.837 (1.408–10.456) | 0.009 | 3.951 (1.428–10.933) | 0.008 |
CLEC3B expression | ||||
High vs low | 0.442 (0.300–0.650) | 0.000 | 0.655 (0.430–0.996) | 0.048 |